S100A8 and breast carcinoma: In addition, analysis based on TCGA breast cancer RNA-seq datasets showed the same trend that S100A8 and S100A9 mRNA was upregulated in ER-, PR-, and Her2 + patients (P < 0.0001, Additional file 2: Figure S1A–B).